Literature DB >> 1775927

Helicobacter pylori and gastric acid secretion: the ulcer link?

J W Rademaker1, R H Hunt.   

Abstract

Helicobacter pylori is a recognized cause of chronic active gastritis and is frequently associated with peptic ulcer disease, but its effect on acid secretion is unclear. Transient hypochlorhydria occurs with acute infections. Despite the theoretical possibility of an increase in parietal cell mass or a response to stimulation occurring secondary to the associated hypergastrinaemia observed with H. pylori, no consistent increase in basal, pentagastrin-stimulated acid secretion or 24-h intragastric acidity has been reported. Although H. pylori is accepted as one of the many factors involved in peptic ulcer disease, and eradication results in decreased ulcer recurrence, its pathogenic role is still poorly understood. The progression of chronic active gastritis to atrophic gastritis and hypochlorhydria may in part explain the natural tendency for duodenal ulcer disease to resolve.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1775927

Source DB:  PubMed          Journal:  Scand J Gastroenterol Suppl        ISSN: 0085-5928


  8 in total

1.  Helicobacter pylori augments the acid inhibitory effect of omeprazole on parietal cells and gastric H(+)/K(+)-ATPase.

Authors:  W Beil; K F Sewing; R Busche; S Wagner
Journal:  Gut       Date:  2001-02       Impact factor: 23.059

2.  Circadian gastric acidity and Helicobacter pylori infection in patients with chronic pancreatitis.

Authors:  V Savarino; G S Mela; P Zentilin; C Mansi; M R Mele; N Pandolfo; V Pugliese; S Vigneri
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

3.  Gastric histology, serological markers and age as predictors of gastric acid secretion in patients infected with Helicobacter pylori.

Authors:  M H Derakhshan; E El-Omar; K Oien; D Gillen; V Fyfe; J E Crabtree; K E L McColl
Journal:  J Clin Pathol       Date:  2006-04-27       Impact factor: 3.411

4.  Non-steroidal anti-inflammatory drugs and prostaglandin effects on pepsinogen secretion by dispersed human peptic cells.

Authors:  A I Lanas; J Nerín; F Esteva; R Sáinz
Journal:  Gut       Date:  1995-05       Impact factor: 23.059

Review 5.  Optimizing acid suppression for treatment of acid-related diseases.

Authors:  R H Hunt; C Cederberg; J Dent; F Halter; C Howden; I N Marks; S Rune; R P Walt
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

6.  Bile acid reflux and possible inhibition of Helicobacter pylori infection in subjects without gastric surgery.

Authors:  Y Kawai; S Tazuma; M Inoue
Journal:  Dig Dis Sci       Date:  2001-08       Impact factor: 3.199

7.  Effect of Helicobacter pylori eradication on 24-hour gastric pH and duodenal gastric metaplasia.

Authors:  V Savarino; G S Mela; P Zentilin; M R Mele; G Bisso; M Pivari; C Mansi; L Tessieri; G Lapertosa; P Ceppa; S Vigneri
Journal:  Dig Dis Sci       Date:  2000-07       Impact factor: 3.199

8.  Improved fold width and increased acid secretion after eradication of the organism in Helicobacter pylori associated enlarged fold gastritis.

Authors:  Y Yasunaga; Y Shinomura; S Kanayama; M Yabu; T Nakanishi; Y Miyazaki; Y Murayama; J J Bonilla-Palacios; Y Matsuzawa
Journal:  Gut       Date:  1994-11       Impact factor: 23.059

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.